北韦生物技术扩展了病毒清除研究,加快了生物制药发展的成果。 Northway Biotech expands Viral Clearance Studies, speeding up results for biopharmaceutical development.

Northway Biotech,一家生物制药公司,现在在六个新的BSL-2实验室提供病毒清除研究(VCS)。 Northway Biotech, a biopharmaceutical company, now offers Viral Clearance Studies (VCS) in six new BSL-2 laboratories. 这种扩大使它们能同时为多个客户提供服务,并比行业标准更快地完成研究,结果为两种病毒模型提供10周以下,4种病毒模型提供12周以下。 This expansion allows them to serve multiple clients simultaneously and complete studies faster than industry standards, with results in under 10 weeks for two model viruses and 12 weeks for four. 这项服务旨在减少生物制药发展中的市场瓶颈。 This service aims to reduce market bottlenecks in biopharmaceutical development.